Skip to main content

Table 1 Demographic data in 1367 colorectal cancer patients

From: Preoperative serum carcinoembryonic antigen, albumin and age are supplementary to UICC staging systems in predicting survival for colorectal cancer patients undergoing surgical treatment

Variable

Case No.

Percentage (%)

Age

  

   <65 years/≥65 years

624/743

45.6%/54.4%

Gender

  

   Male/Female

757/610

55.4%/44.6%

Tumor size

  

   ≥5 cm/<5 cm

539/774

39.4%/60.6%

Tumor location

  

   Colon/Rectum

920/447

67.3%/32.7%

Histological type

  

   Well/Moderately/Poorly

183/1066/118

13.4%/77.9%/8.7%

UICCa Stage

  

   I/II/III/IV

230/506/391/240

16.8%/37.1%/28.6%/17.5%

Tumor invasion

  

   T1/T2/T3/T4

70/229/989/80

5.1%/16.7%/72.4%/5.8%

Node metastases

  

   N0/N1/N2

832/343/192

60.8%/25.2%/14.0%

Serum Albumin level

  

   <3.5 gm/dl/≥3.5 gm/dl

392/975

28.7%/71.3%

Serum CEAblevel

  

   ≥5 ng/ml/<5 ng/ml

634/724

46.4%/53.6%

  1. aInternational Union Against Cancer
  2. bCarcinoembrynic antigen
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us